Literature DB >> 2194921

Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension.

J Reichen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194921     DOI: 10.1002/hep.1840110625

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  11 in total

Review 1.  Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

Authors:  J Vlachogiannakos; A K Tang; D Patch; A K Burroughs
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

Review 2.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

3.  Effects of pharmacological serum from normal and liver fibrotic rats on HSCs.

Authors:  Xi-Xian Yao; Tao Lv
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

4.  The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage.

Authors:  Y Tsushima; J K Blomley; S Kusano; K Endo
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

5.  Murine study of portal hypertension associated endothelin-1 hypo-response.

Authors:  Nicholas Theodorakis; Mary Maluccio; Nicholas Skill
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

Review 6.  A practical guide to the management of oesophageal varices.

Authors:  G McCormack; P A McCormick
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

7.  Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Authors:  Frédéric Moal; Nary Veal; Eric Vuillemin; Eric Barrière; Jianhua Wang; Lionel Fizanne; Frédéric Oberti; Olivier Douay; Yves Gallois; Dominique Bonnefont-Rousselot; Marie Christine Rousselet; Paul Calès
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits.

Authors:  P A Cahill; Y Wu; J V Sitzmann
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

10.  Intrahepatic portal occlusion by microspheres: a new model of portal hypertension in the rat.

Authors:  V Jaffe; B Alexander; R T Mathie
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.